Drug intelligence / Profile preview

alisol a 24-acetate

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

**Alisol A 24-acetate** is a protostane-type tetracyclic triterpenoid, one of the main active compounds found in *Rhizoma Alismatis* (tuber of Alisma orientale), a traditional Chinese medicinal herb. It is a natural product with multitarget pharmacological activities, notably **anti-inflammatory, antioxidant, anti-apoptotic, hypolipidemic, and anti-atherosclerotic effects**[1][3][4][5][7]. Mechanistic studies show it inhibits neuroinflammation and apoptosis (via downregulation of microglia and astrocyte proliferation, reduced TNF-α, IL-1β, iNOS, and promotion of PI3K/AKT pathway activity) and suppresses oxidative stress and stimulates autophagy through AMPK/mTOR pathways[1]. Animal studies support its role in **alleviating ischaemic stroke injury (neuroprotection)** and in the **treatment and prevention of obesity** by reducing blood lipids, as well as showing benefit in **osteoarthritis** (inhibition of reactive oxygen species and inflammatory response)[1][3][5]. It may also induce autophagy and apoptosis, potentially contributing to nephrotoxicity, indicating both therapeutic and safety considerations[7]. No pharmaceutical brand names or approved products are recognized; it's primarily studied as a **reference standard**, natural product, or pharmaceutical intermediate in research.

Other names
alisol a 24-acetatealisol a 24-monoacetate24-o-acetylalisol a(8α,9β,14β,23S,24R)-11β,23,25-trihydroxy-24-acetoxydammar-13(17)-en-3-onealisol a 24-o-acetate[4]
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)MAPK3 (Mitogen-activated protein kinase 1)AKT (RAC-alpha serine/threonine-protein kinase)mTOR (Mammalian target of rapamycin kinase)

Beyond the preview

Go deeper on alisol a 24-acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alisol a 24-acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call